You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic for the treatment of patients with transthyretin cardiac amyloidosis
|
|---|---|
| Published in |
Orphanet Journal of Rare Diseases, November 2015
|
| DOI | 10.1186/1750-1172-10-s1-o21 |
| Authors |
Julian D Gillmore, Rodney H Falk, Mathew S Maurer, Mazen Hanna, Verena Karsten, John Vest, Jared Gollob, Philip N Hawkins |
Mendeley readers
The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 26 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 3 | 12% |
| Student > Ph. D. Student | 3 | 12% |
| Professor | 2 | 8% |
| Student > Doctoral Student | 2 | 8% |
| Researcher | 2 | 8% |
| Other | 7 | 27% |
| Unknown | 7 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 31% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 8% |
| Nursing and Health Professions | 2 | 8% |
| Biochemistry, Genetics and Molecular Biology | 2 | 8% |
| Social Sciences | 2 | 8% |
| Other | 2 | 8% |
| Unknown | 8 | 31% |